Hepatocellular carcinoma (HCC) is a common malignancy in developing countries and its
incidence is on the rise in the developing world. The epidemiology of this cancer is unique …

Tumor biomarkers are important in the early screening, diagnosis, therapeutic evaluation,
recurrence and prognosis prediction of tumors. Primary liver cancer is one of the most …

Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality and has an
increasing incidence worldwide. HCC can be induced by multiple etiologies, is influenced …

Primary liver cancer is the fifth most common cancer worldwide and hepatocellular
carcinoma (HCC) accounts for over 85% of all primary liver cancers. The clinical …

Hepatocellular carcinoma (HCC) is one of the few cancers in which a continued increase in
incidence has been observed over several years. As such, there has been a focus on safe …

Early reports suggested androgen/androgen receptor (AR) signals promote
hepatocarcinogenesis. However, all antiandrogen clinical trials failed in advanced …

Conventional approaches to prognostic classification and treatment recommendations for
the worldwide burden that is hepatocellular carcinoma (HCC) 1 have largely relied on …

Background: Hepatocellular carcinoma (HCC) is one of the most common and deadly
malignancies worldwide. The multikinase inhibitor sorafenib still remains the only approved …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. The
mechanisms for male propensity in HCC incidence, prognosis and treatment responses are …

Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third
leading cause of cancer-related death. The high rate of diagnosis in non-curable stages and …